EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Diagnostic Utility of the Central Vein Sign in Multiple Sclerosis With Implementation of the 6 Lesion Rule

Seham S. Alsalamah, Salem S. AlSumai, Ali H. Alsubaie, Shaikha A. Alshehhi, Muath M. Alqahtani, Mohammed A. Alajlan, Khalid Alsuhaibani, Sameeha Fallatah, Yaser Al Malik, Seraj O. Makkawi, Omar Aldibasi, Ahmad A. Abulaban

Neurosciences · 30.10.2026 · 31 (4) · 380-390

DOI: 10.17712/1658-3183.2817 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurosciences, online erschienen am 30.10.2026. Verfasst von Seham S. Alsalamah und 11 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To evaluate the diagnostic value of the central vein sign (CVS) using specific magnetic resonance imaging (MRI) sequences, such as susceptibility-weighted imaging (SWI) and gradient echo sequence (GRE), while also assessing its association with cardiovascular risk factors. The central vein sign is a radiological biomarker proposed as a differentiating tool between multiple sclerosis (MS) and nonspecific white matter diseases (WMD), addressing the high rate of MS misdiagnosis.

Methods

In this case-control study, investigators who were blinded to patients' clinical and demographic data reviewed the brain MRI scans of 598 consecutive patients between January 2016 and August 2022 for the occurrence of the CVS. A total of 422 participants were included after excluding 176 patients.

Results

In total, 5939 brain lesions were analyzed: 4773 in 245 patients with MS and 1166 in 177 patients with other WMDs. In patients with MS, the CVS was detected in 1300 lesions (27.23%). The specificity of the 3- and 6-CVS lesion criteria was 89.8% and 100%, respectively. In the multivariate regression model, hypertension and the onset of optic neuritis were independently and negatively associated with the CVS.

Conclusion

This study demonstrates that the CVS is highly specific in differentiating MS from other WMDs, suggesting that its integration into the MS diagnostic criteria could enhance MS diagnosis and improve patient outcomes.

Zitieren

APA

Alsalamah, S. S., AlSumai, S. S., Alsubaie, A. H., Alshehhi, S. A., Alqahtani, M. M., Alajlan, M. A., Alsuhaibani, K., Fallatah, S., Malik, Y. A., Makkawi, S. O., Aldibasi, O., & Abulaban, A. A. (2026). Diagnostic Utility of the Central Vein Sign in Multiple Sclerosis With Implementation of the 6 Lesion Rule. Neurosciences, 31(4), 380-390. https://doi.org/10.17712/1658-3183.2817

Vancouver

Alsalamah SS, AlSumai SS, Alsubaie AH, Alshehhi SA, Alqahtani MM, Alajlan MA, et al. Diagnostic Utility of the Central Vein Sign in Multiple Sclerosis With Implementation of the 6 Lesion Rule. Neurosciences. 2026;31(4):380-390. doi:10.17712/1658-3183.2817

BibTeX
@article{Alsalamah2026,
  author = {Alsalamah, Seham S. and AlSumai, Salem S. and Alsubaie, Ali H. and Alshehhi, Shaikha A. and Alqahtani, Muath M. and Alajlan, Mohammed A. and Alsuhaibani, Khalid and Fallatah, Sameeha and Malik, Yaser Al and Makkawi, Seraj O. and Aldibasi, Omar and Abulaban, Ahmad A.},
  title = {Diagnostic Utility of the Central Vein Sign in Multiple Sclerosis With Implementation of the 6 Lesion Rule},
  journal = {Neurosciences},
  year = {2026},
  volume = {31},
  number = {4},
  pages = {380--390},
  doi = {10.17712/1658-3183.2817}
}
Kostenlos starten →